Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-16

FDA Approved: ABACAVIR — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ABACAVIR submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

SUPPL AP for ABACAVIR (ABACAVIR)